Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HMGN2P47 is a noncoding pseudogene in humans, formally identified as high mobility group nucleosomal binding domain 2 pseudogene 47. As a pseudogene, HMGN2P47 shares high sequence homology with the functional HMGN2 gene, which encodes a member of the high-mobility group chromosomal protein family involved in chromatin structure and regulation. However, HMGN2P47 itself does not code for a functional protein product and is not involved in normal or pathogenic biological pathways as an active molecule[3][5][7]. While some pseudogenes can exert regulatory effects (e.g., acting as competitive endogenous RNAs or miRNA decoys), there is no specific evidence in the literature for such a role for HMGN2P47[2][4]. It is not considered a therapeutic target, is not associated with any known drugs, and does not serve as a biomarker or have notable safety considerations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group nucleosomal binding domain 2 pseudogene 47 (HMGN2P47).